Sun Has a Better Shot Than Most at Ranbaxy Turnaround

There are apprehensions on whether Dilip Shanghvi's company can help India's largest but troubled pharma major turn around. However, analysts, while sceptical, also point out that Sun Pharma has a better shot than most

(A link to this page will be included in your message)


Email

Your Name
Required
Email Address
Required
 Send me a copy
Recipient's Email Address
Required
Separate multiple email addresses with commas (max 20)
Your Message
(1000 characters max)
"The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party."